Clinical trial · Observational
French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer.
Memorial Anxiety Scale for Patients With Prostate Cancer: French Validation, Links With Quality Of Life and Future Temporal Perspective.
NCT03331068CI-TRIAL-00030230completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A specific scale allowing the measure of anxiety of patients with protate cancer has been designed and validated but the French version needs to be validated. This study aims at validating the French translation of this scale.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| online questionnaire of MAX-PC | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with prostate cancer
- description
- online questionnaire of MAX-PC
- interventionNames
- Behavioral: online questionnaire of MAX-PC
Primary outcomes (1)
- measure
- Total anxiety score assessed by the Memorial Anxiety Scale for Prostate Cancer (MAX-PC scale)
- timeFrame
- At inclusion
- description
- The scale is divided in 3 subscales: Prostate cancer Anxiety ; PSA anxiety and Fear of Recurrence. The total score of the scale ranges from 0 to 54, with 54 indicating maximum anxiety. Scores of the Prostate anxiety scale range from 0 to 33 ; with 33 indicating maximum anxiety. Scores of the PSA anxiety scale range from 0 to 9 ; with 9 indicating maximum anxiety. Score of the Fear of Recurrence scale range from 0 to 12; with 12 indicating maximum anxiety. The total score is the sum of the 3 subscales scores.
Secondary outcomes (3)
- measure
- Quality of Life (QoL) scores assessed by the SF-12 scale
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with prostate cancer diagnosed within 12 months Exclusion Criteria: N/A
References
Publications (0)
Data not yet available
No reference posted for this study.